Navigation Links
SHERIDAN CF® Endotracheal Tubes

ProductsSHERIDAN CF® Endotracheal Tubes
Company Hudson RCI
Item SHERIDAN CF® Endotracheal Tubes
Features 
  • Close fitting, low pressure cuff for short-term surgical intubation
  • Close fitting design eases intubation
  • Opaque cuff color increases visualization
  • Oral/Nasal length available with Murphy Eye or Magill style
  • Individually packaged sterile, 10 per case
  • Latex Free: Murphy Eye or Magill Style
  • Description Close fitting, low pressure cuff.

    Sheridan Endotracheal Tubes offer the features needed by today's healthcare professionals.
  • High level of tactile feedback from pilot balloon
  • Thermosensitive PVC allows the tube to soften at body temperature
  • Smooth tube tip, molded and gently cupped to minimize trauma during intubation
  • Two distinct cuff types: High Volume Tapered (HVT) and Close Fitting (CF)
  • 100% Latex-Free
  • Info Hudson RCI
    Customer Service: (800) 399-1039
    Web site: http://www.hudsonrci.com

    Related medicine products :

    1. SHERIDAN HVT® Endotracheal Tubes
    2. SHERIDAN NAZ-AL™ Endotracheal Tubes
    3. SHERIDAN ETCO2 Uncuffed Endotracheal Tubes
    4. SHERIDAN EZ-ENDO™ Endotracheal Tubes
    5. SHERIDAN PREFORMED Nasal Endotracheal Tubes
    6. SHERIDAN PREFORMED Oral Endotracheal Tubes
    7. SHERIDAN LAR-A-JECT® Reinforced Laryngectomy Tubes
    8. SHERIDAN ETCO2™ Uncuffed Endotracheal Tubes
    9. SHERIDAN LTS Endotracheal Tubes
    10. SHERIDAN LITA Cuffed Endotracheal Tube
    11. SHERIDAN LASER-TRACH Endotracheal Tubes
    ... an innovative handheld device for ... non-invasively, comfortably, and accurately.,It is, ... than an automatic blood pressure ... charge, Vasotrax will take approximately ...
    ... Insulin-like growth factor II (IGF-II) is a 7.5 ... liver and is postulated to have mitogenic and ... of IGF-II are mediated by binding to target ... the Type II IGF receptor, a monomeric protein ...
    ... Pregnancy-associated plasma protein A (PAPP-A) is ... is produced in high concentrations by ... into the maternal circulation in increasing ... PAPP-A is not specific to pregnancy ...
    ... Pregnancy-associated plasma protein A (PAPP-A) ... PAPP-A is produced in high concentrations ... released into the maternal circulation in ... [1]. PAPP-A is not specific to ...
    Medicine Products:
    (Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
    (Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
    (Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
    (Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
    (Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
    Breaking Medicine News(10 mins):
    (Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
    (Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
    (Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
    Breaking Medicine Technology: